Introduction: the antigen CD28, expressed in most T cells, has co-stimulato
ry properties and plays a pivotal role in clonal T cell anergy mechanisms.
Methods: we have compared proliferative T cell responses after anti-CD3 or
in phorbol myristate acetate activation with concomitant CD28 signal in per
ipheral blood mononuclear cells from healthy donors aged over 65 [elderly d
onors; ED] and young healthy donors (YD; mean age 30 +/- 2.7 years).
Results: no proliferative responses were observed in ED and YD with anti-CD
28 monoclonal antibody alone. These responses both were defective in ED, pa
rticularly after anti-CD3 monoclonal antibody stimulus (7604 compared with
12 438 c.p.m. in YD, P = 0.001) and were corrected when anti-CD28 monoclona
l antibody was added to the culture (17 216 vs 18 536, not significant). Fu
nctional integrity of the CD28 co-stimulatory pathway was demonstrated by a
nalysis of CD25 expression, interleukin-2 secretion and interleukin-2 gene
expression on T cells from ED and YD. Age-associated phenotypic T cell chan
ges were not crucial for an adequate CD28 response,
Conclusion: these experiments demonstrate the integrity of the CD28 pathway
in elderly people, and suggest that ageing does not affect different T cel
l activation pathways equally.